Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Contraindications and Precautions Consider avoiding BPC-157 if you have: History of cancer or active malignancy Pregnancy or breastfeeding (no safety data) Competitive athletic status (WADA prohibits peptides) Known sensitivity to peptide products Severe cardiovascular disease (limited data) Blood pressure monitoring may be prudent given the nitric oxide modulation effects
Pharmacological risks : Even if the product is genuine, the adverse effect profile of retatrutide as observed in the published phase 2 clinical trial includes nausea, vomiting, diarrhoea, decreased appetite, and injection-site reactions
Fresh solutions should be prepared for each experiment, as stock solutions degrade over repeated handling and freeze-thaw cycling
Aluminum may reach toxic levels with prolonged parenteral administration if kidney function is impaired
JCI Insight 2 , e88735 (2017)
.png?w=1280&max-h=720&fit=crop&auto=format)
